NCT06406855Not yet recruiting

Brain-Controlled Spinal Stimulation Walking Therapy After Incomplete Spinal Cord Injury (SCI)

Name: Clinical Trial NCT06406855
Creator: University of Miami
Keywords: Spinal Cord Injuries, BCI-TSCS, other, clinical trial, United States of America

Brain-Controlled Spinal Stimulation Therapy for Restoration of Walking After Incomplete Spinal Cord Injury (SCI)

University of MiamiClinicalTrials.govother

Verified

Study focus

Disease/Condition: Spinal Cord Injuries
Drug/Device/Intervention: BCI-TSCS
Study type: Interventional
Intervention type: other

Sponsor & location

Primary sponsor: University of Miami
Location: Miami, United States of America

Timeline & enrollment

Phase: N/A
Start date: Jul 31, 2024
End date: Dec 31, 2025
Enrollment: 12 participants

Primary outcome

Number of related neurological deterioration (LEMS),Number of treatment related incidence of adverse events (AEs),Number of subjects that complete the study,Walking function using 10 meter walk test (10MWT),Walking function using 6 minute walk test (6MWT)

Summary

The purpose of this research is to test the effectiveness of a new therapy, called Brain-Computer Interface (BCI)-Transcutaneous Spinal Cord Stimulation (TSCS), for improving walking in people with an incomplete spinal cord injury (SCI).

ICD-10 classifications

Sequelae of injury of spinal cordOther and unspecified injuries of thoracic spinal cordOther and unspecified injuries of cervical spinal cordOther injury of lumbar spinal cordInjury of spinal cord, level unspecified

Data source

Registry: ClinicalTrials.gov
Trial ID: NCT06406855
Type: Non-Device Trial

About this record

Access comprehensive clinical trial information for NCT06406855 through Pure Global AI's free database. This phase not specified trial is sponsored by University of Miami and is currently Not yet recruiting. The study focuses on Spinal Cord Injuries. Target enrollment is 12 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.